Cargando…

Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation

A quarter-century after the discovery of autotaxin in cell culture, the autotaxin-lysophosphatidate (LPA)-lipid phosphate phosphatase axis is now a promising clinical target for treating chronic inflammatory conditions, mitigating fibrosis progression, and improving the efficacy of existing cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benesch, Matthew G.K., MacIntyre, Iain T.K., McMullen, Todd P.W., Brindley, David N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876648/ https://www.ncbi.nlm.nih.gov/pubmed/29543710 http://dx.doi.org/10.3390/cancers10030073

Ejemplares similares

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo
por: Benesch, Matthew G.K., et al.
Publicado: (2016)

Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
por: Brindley, David N., et al.
Publicado: (2020)

Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis
por: Meng, Guanmin, et al.
Publicado: (2020)

Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle
por: Meng, Guanmin, et al.
Publicado: (2019)

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae
por: Benesch, Matthew G. K., et al.
Publicado: (2020)

Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling
por: Eymery, Mathias C, et al.
Publicado: (2023)

PDGFRα Enhanced Infection of Breast Cancer Cells with Human Cytomegalovirus but Infection of Fibroblasts Increased Prometastatic Inflammation Involving Lysophosphatidate Signaling
por: Yang, Zelei, et al.
Publicado: (2021)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
por: Shin, Eunah, et al.
Publicado: (2019)

MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019)

The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
por: Erstad, Derek J., et al.
Publicado: (2017)

Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
por: Keune, Willem-Jan, et al.
Publicado: (2016)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
por: Yun, C. Chris
Publicado: (2019)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin
por: Clair, Timothy, et al.
Publicado: (2005)

Expression of Autotaxin–Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma
por: Cha, Yoon Jin, et al.
Publicado: (2019)

The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin–lysophosphatidic acid as a new therapeutic target?
por: Gallardo, Felipe S., et al.
Publicado: (2021)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Autotaxin-Lysophosphatidic Acid Axis Is a Novel Molecular Target for Lowering Intraocular Pressure
por: Iyer, Padma, et al.
Publicado: (2012)

Autotaxin/lysophosphatidic acid signaling mediates obesity‐related cardiomyopathy in mice and human subjects
por: Weng, Jiakan, et al.
Publicado: (2018)

KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers
por: Wang, Shuo, et al.
Publicado: (2022)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar, Sabrina, et al.
Publicado: (2020)

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
por: Tigyi, Gábor, et al.
Publicado: (2021)

Disrupted Blood‐Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
por: Bhattarai, Susmita, et al.
Publicado: (2021)

Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3
por: Tang, Xiaoyun, et al.
Publicado: (2019)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
por: Umezu-Goto, Makiko, et al.
Publicado: (2002)

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
por: Flores-López, María, et al.
Publicado: (2021)

Correction to: Disrupted Blood–Brain Barrier and Mitochondrial Impairment by Autotaxin–Lysophosphatidic Acid Axis in Postischemic Stroke
Publicado: (2023)

Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not
por: Tang, Xiaoyun, et al.
Publicado: (2023)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

ADSCs and adipocytes are the main producers in the autotaxin–lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro
por: Schmid, Rafael, et al.
Publicado: (2018)

Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines
por: Hauck, Theresa, et al.
Publicado: (2022)

Autotaxin and lysophosphatidic acid(1 )receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine
por: Nagai, Jun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uu0fitvmbujfm83vc1a40ac37t